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POLYMORPHIC VARIANTS IN INTRON 1 OF BMP5 ARE 
ASSOCIATED WITH HIP OSTEOARTHRITIS 
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Background: We have mapped a female-hip OA susceptibility 
locus to chromosome 6 within an interval that encompasses the 
BMP5 gene. This gene codes for the growth factor bone morpho- 
genetic protein 5. BMP5 is expressed in a wide variety of tissues 
of the adult articulating joint (see abstract by Wilkins et al) with 
the BMP5 protein having a critical role in the development and 
maintenance of joint tissues. BMP5 is therefore a logical candi- 
date for OA susceptibility. Our initial analysis of the gene failed to 
detect significant association (P _< 0.05) to BMP5 coding SNPs. 
However, association was detected to microsatellites within non- 
coding and flanking regions of the gene. This data implied that cis 
regulatory elements of BMP5 might code for susceptibility to OA. 
This notion was supported by our observation that a high propor- 
tion of OA patients demonstrate differential allelic expression of 
BMP5 in articular cartilage (Wilkins et al.). 
Aim of study: To conduct a more comprehensive association 
analysis of BMP5 that includes the intronic and flanking se- 
quences of the gene. 
Methods: Twenty-two SNPs and 27 polymorphic microsatellite 
markers from within a 695kb interval of chromosome 6 that en- 
compasses BMP5 and its flanking sequences were genotyped in 
a cohort of unrelated female cases with hip OA and age-matched 
female controls. Alleles, genotypes and haplotypes of the poly- 
morphisms were then tested for association by chi-square analy- 
sis. 
Results: An association was detected to 2 SNPs and an adja- 
cent microsatellite marker located within a 6 kb interval of intron 
1 of BMP5. The two SNPs are in sequence elements that show 
greater than 70% conservation between humans and mice, imply- 
ing that they may have a functional role. The 2 SNPs and the mi- 
crosatellite are in strong to moderate LD (D' > 0.8) and therefore 
appear to be marking the same association. A haplotype analysis 
failed to generate more significant data than the markers alone. 
Conclusions: We have generated evidence to suggest that in- 
tron 1 of BMP5 codes for OA susceptibility in females with hip 
OA. We suspect that effects on the expression of BMP5 may me- 
diate this association. 
Acknowledgements: Supported by Research into Ageing and 
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Objective: The association between the polymorphisms in es- 
trogen receptor o~ (ESR1) gene and OA susceptibility has been 
reported but the findings are still controversial. The objective of 
this study was to rationally explain the association with the com- 
bination of several ESR1 SNPs. 
Method: The medical records and DNA samples were obtained 
from 418 unrelated Japanese, 115 non-OA subjects and 303 
symptomatic primary knee OA patients (mean age of 76.2 4- 8.0, 
65 males and 353 females). We genotyped three ESR1 SNPs: 
two well-known intronic SNPs (Pvu II and Xba I) and one synony- 
mous SNP in exon 8. Tibiofemoral joint spaces were measured 
and stratified into quartile according to the scores. The symp- 
tomatic OA patients with radiographic grades of 3 or more were 
included in this study. 
Result: The genotype distributions did not deviate from the HWE, 
but the frequency of Xba I was significantly different from that of 
Caucasians. There found no difference of frequencies between 
OA and non-OA groups in each genotype, allele and the haplo- 
type of these 3 SNPs. Also, the haplotypes or diplotype of Pvu II 
and Xba I could not distinguish these groups. However, consid- 
ering the synonymous SNP genotype with Pvu II - Xba I diplo- 
type, subjects with PpXx diplotype were clearly separated into 
two groups: a risk group and a protective one (PpXx GG(+) group 
vs. PpXx GG(-) group). The distributions of the subjects without 
PpXx genotype were not significantly different and we catego- 
rized them as "the others". The age, BMI, female ratio, duration 
and onset age were not different between these 3 groups. PpXx 
GG(-) genotype had a significantly protective effect (OR = 0.4; 
95% CI: 0.2 to 0.9; p = 0.03). Contrary, PpXx GG(+) genotypes 
were more frequently observed in OA subjects compared to other 
genotype combination (p = 0.04). This tendency was more ap- 
parent in females. We also examined whether the tibiofemoral 
joint space narrowing is associated with these diplotypes. In the 
subjects of PpXx GG(-) group, a significant positive trend was 
observed from the lowest to the highest quartiles of tibiofemoral 
joint space (trend p = 0.0295). This trend was more apparent in 
females (overall p = 0.0368, trend p = 0.0241). 
Conclusion: In our study population, ESR1 Pvu II - Xba I diplo- 
type was essential, but not enough to distinguish the primary 
symptomatic knee OA. By combining with another synonymous 
SNP, we successfully divided risk and protective groups. Further 
investigation of the characteristics of the patients possessing the 
protective genotype could lead a discovering of mechanisms and 
better treatments to protect the patients from progression of the 
disease. 
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Aim of study: To investigate whether small interefering RNA 
(siRNA) suppress the expression of tumor necrosis factor (TNF)- 
and interleukin (IL)-I I~ in synovial fibroblasts of rat in vitro. 
Methods: Four siRNA duplexes specific for TNF-~ or IL-11~ were 
prepared and transduced into cultured peritoneal macrophages 
of rats by the transfection reagents. The expression level of TNF- 
and IL-11~ in supernatant was measured by ELISA after stimu- 
lation with lipopolysaccalide. The most effective siRNA was used 
in the following experiments. Synovial fibroblasts were isolated 
from synovial tissues of knee and ankle joints of collagen induced 
arthritis rats. Alexa-fluor 488 labeled siRNA was transduced into 
synovial fibroblasts by the transfection reagents. The transduced 
cells were observed under fluorescent microscope and the trans- 
duction efficacy was examined. TNF-~ or IL-11~ specific siRNA, 
and negative control siRNA were transduced into cultured syn- 
ovial fibroblast. The total RNA was extracted from these cells. 
The expression levels of TNF-o~ and IL-11~ mRNA were analyzed 
by quantitative real-time PCR. 
Results: All four types of TNF-o~ or IL-11~ specific siRNA 
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suppressed the secretion of TNF-~ and IL-11~ by peritoneal 
macrophages. The most potent silencing effects was 90% and 
60% suppression, respectively. Fluorescent labeled siRNA was 
found to be transduced into almost all of the cells. TNF-~ and IL- 
l I~ mRNA level of siRNA transfected synovial fibroblasts were 0.3 
fold and 0.2 fold of control cells. 
Conclusions: RNA interference (RNAi) is the powerful means 
of silencing genes, and the effect is sequence specifically. Re- 
cently, several studies applied RNAi to treat of various disorders 
in animal models, and showed that RNAi may improve promiss- 
ing strategies to treat human diseases by silencing disease- 
responsible genes in vivo. In the pathogenesis of osteoarthri- 
tis (OA) and rheumatoid arthritis (RA), various inflammatory cy- 
tokines produced by synovium leads to destruction of joints. In 
particularly, TNF-~ and IL-11~ is known as a key mediator of OA 
and RA. Therefore, to suppress the expression of TNF-~ and IL-I~ 
in joints in vivo is expected an effective and less invasive con- 
servative therapy of joint disease. In this study, TNF-~ or IL-11~ 
specific siRNA were transduced into synovial fibroblasts uccess- 
fully, and suppress the expression of TNF-~ and IL-11~ in synovial 
fibroblasts in vitro. 
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Objective: Matrix metalloprotenases (MMPs) are the most crit- 
ical proteinases to degrade the extracellular matrix of OA carti- 
lage. The objective of this study is to investigate the association 
between MMP-1 single nucleotide polymorphisms (SNPs) and 
primary knee OA progression. 
Subjects: The medical records and DNA samples were obtained 
from 418 unrelated Japanese, 115 non-OA subjects and 303 
knee symptomatic primary knee OA patients having radiographic 
grade 3 or more (mean age of 76.2 4- 8.0, 65 males and 353 fe- 
males). Non-OA population consisted of volunteers without any 
symptom and/or sign of OA who had visited these hospitals for 
fractures, injured or other orthopedic disease. Genotyping was 
performed using LightTyper and melting curve analysis. 
Results: Three SNPs were not in linkage disequilibrium. As we 
found one genotype frequency was significantly different between 
the OA progression stages, we hereafter focused on this SNP, 
1655A/G. The frequencies of AA and AG+GG group subjects in 
stage 1-2, 3 and 4 were 0.28, 0.40, 0.32 and 0.25, 0.53, 0.22, 
respectively (P= 0.0190). Age BMI, and sex ratio were not differ- 
ent significantly between these genotype groups. Therefore, we 
hypnotized that AA group subjects more likely to progress OA. 
Indeed, the medial tibiofemoral joint spaces were narrower in AA 
group subjects (adjusted to age, sex and BMI, P = 0.0158). More- 
over, this tendency was apparent in the highest tertile of BMI (> 
25.8, P= 0.0160) whereas those in the lowest and middle groups 
were not different significantly. 
Conclusion: This study suggested that one SNP in MMP1 is 
associated with knee OA severity. This SNP could be a useful 
marker to prospect the progression of knee OA. It might be bet- 
ter to recommend the patients who possess the risk genotype to 
reduce body weight for slowing the progression. Further inves- 
tigation of the molecular aspects of this SNP, or the searching 
other truly responsible SNPs may clarify the role(s) of MMP1 in 
the cartilage and the mechanisms of OA progression. 
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DOES TROCHLEAR CARTILAGE ANALYSIS FROM 
QUANTITATIVE MAGNETIC RESONANCE IMAGING 
PROVIDE INFORMATION THAT PATELLAR ANALYSIS 
DOES NOT'?. 
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Aim:Patellar and femoral (trochlear) cartilage morphology can- 
not be evaluated separately on plain radiographs. Quantitative 
MR imaging, however, can provide these data with high accuracy 
and precision, but it is unclear whether it is sufficient to measure 
just the patella, or whether measurement of trochlear cartilage 
provides additional information. We therefore analyzed the corre- 
lation of patellar and trochlear cartilage morphology with quantita- 
tive MR imaging in knees with and without radiographic evidence 
of patellofemoral OA (PFOA) in a community sample. 
Methods:186 subjects from the Framingham cohort (138 women, 
48 men, age 61 4- 7.8 y) were studied. Patellar cartilage mor- 
phology was determined from axial MR images (FLASH VlBE we 
sequence, 1.5 x 0.31 x 0.31 mm 3 resolution), and trochlear car- 
tilage morphology from sagittal images, acquired with the same 
sequence. We determined total area of subchondral bone (tAB), 
percent denuded area of subchondral bone (dAB%), mean and 
maximal cartilage thickness, and cartilage volume (VC), by using 
proprietary software (Chondrometrics GmbH, Ainring, Germany). 
PFOA status was evaluated on lateral radiographs, with PFOA 
being defined as presence of osteophytes grade _> 2, or pres- 
ence of osteophytes grade _> 1 with JSN grade _> 2 in the PF 
joint. 
Results:Of 176 cases without radiographic PFOA, 18.8% dis- 
played areas of denuded cartilage in the patella (dAB% = 0-36%), 
12.5% in the trochlea (0-18%), and 5.7% in both surfaces. Of 
10 cases with PFOA, 60% displayed areas of denuded cartilage 
in the patella (0 to 57%), 80% in the trochlea (0 to 23%), and 
50% in both surfaces. Patellar cartilage thickness differed signif- 
icantly (p < 0.01) in women with (n = 9) and without PFOA (n = 
129), but interestingly trochlear cartilage did not. The correlations 
between patellar and trochlear cartilage in subjects with/without 
PFOA were r = 0.47/0.61 for tAB, r = 0.87/0.62 for VC, and r = 
0.58/0.42 for mean cartilage thickness. 
Conclusions:Denuded cartilage can be seen in a substantial 
proportion of subjects with apparently normal lateral radiographs. 
There are a number of subjects with denuded trochlear cartilage, 
who do not display denuded patellar cartilage at the same time 
(6.8% in subjects without PFOA, and 30% in subjects with PFOA). 
Also, there only exists a moderate correlation between patellar 
and trochlear cartilage morphology in subjects with and without 
radiographic PFOA, with 22% to 76% of the variability in cartilage 
morphology of the trochlea being explained by the variability in 
the patella. In summary, lateral radiographs fail to detect areas of 
full thickness cartilage loss in a considerable number of subjects. 
The results also indicate that analysis of trochlear cartilage mor- 
phology may provide unique and important information in addition 
to measurement of cartilage morphology in the patella. 
